))
Melanoma Insights for Professionals features interviews with leading melanoma specialists who translate the latest research and best practice into the everyday clinic setting. Developed by Melanoma Institute Australia, this series is for multidisciplinary healthcare professionals who want to be across the latest developments in melanoma. For more education, visit melanomaeducation.org.au.
…
continue reading
1
Transforming cancer care: Neoadjuvant therapy and trials in melanoma care
35:46
35:46
Play later
Play later
Lists
Like
Liked
35:46
Neoadjuvant immunotherapy is transforming patient care in the field of melanoma. New research recently presented at the American Society of Clinical Oncology (ASCO) Annual Meeting is set to change melanoma treatment protocols globally, and likely to have significant impact on treatment for other cancers too. In this podcast, A/Prof Matt Carlino lea…
…
continue reading
1
Current and emerging biomarkers for melanoma care
33:25
33:25
Play later
Play later
Lists
Like
Liked
33:25
Biomarkers are revolutionising our understanding of melanoma by providing valuable information about a patient's unique tumour characteristics which can help guide clinical decision making. In this podcast, A/Prof Alex Menzies leads a multidisciplinary discussion on the current state of biomarker application and future prospects of biomarkers in me…
…
continue reading
1
Spotlight on mucosal melanoma: Head and neck
41:12
41:12
Play later
Play later
Lists
Like
Liked
41:12
Mucosal melanoma is a rare and aggressive form of melanoma that arises from the mucous membrane. In this podcast, we focus on mucosal melanoma of the head and neck. Led by A/Prof Sydney Ch’ng, our multidisciplinary experts discuss how it differs from cutaneous melanoma, staging of mucosal melanoma, management of the disease and future treatments. T…
…
continue reading
1
Dealing with diagnostic uncertainty and borderline pathology
41:28
41:28
Play later
Play later
Lists
Like
Liked
41:28
Diagnostic uncertainty in the context of cutaneous melanoma can have significant impact on patient care. In this podcast, our multidisciplinary experts, led by Dr Adrian Quek, discuss the challenges faced in classifying melanocytic lesions that fall into a diagnostic grey area, and explore the terminology, evolving classifications and the impact of…
…
continue reading
With the advent of effective medical therapies for melanoma, a pertinent question has arisen: When should we scan our patients? In this podcast, our multidisciplinary experts, led by A/Prof Sydney Ch’ng, discuss the balance of whether we should be more aggressive in our pursuit of identifying potential metastases or exercise caution to avoid unnece…
…
continue reading
1
When to recommend a sentinel node biopsy in melanoma
33:03
33:03
Play later
Play later
Lists
Like
Liked
33:03
Sentinel node biopsy (SNB) plays a key role in assessing the prognosis of melanomas. In this fireside chat from our new SNB Training Program (Sentinel Node Biopsy: From guidelines to practice), MIA’s Prof Georgina Long AO, Prof John Thompson AO and A/Prof Sydney Ch’ng discuss: the history of SNB in the management of melanoma its current role in the…
…
continue reading
1
Neoadjuvant immunotherapy: Revolutionising melanoma treatment
35:55
35:55
Play later
Play later
Lists
Like
Liked
35:55
Our latest podcast explores the innovative approach of neoadjuvant immunotherapy - administering checkpoint inhibitor immunotherapy before the surgical removal of melanoma. This promising approach is creating a buzz among multidisciplinary clinicians and researchers globally as the potential benefits for melanoma patients are being realised. Althou…
…
continue reading
Lentigo maligna – a subtype of in situ melanoma – presents diagnostic and treatment challenges for clinicians. In this podcast, Dr Michael Rtshiladze leads a multidisciplinary discussion to unravel our understanding of the pathology, diagnosis and management of lentigo maligna, including: clinical and histological presentation tools to diagnose and…
…
continue reading
1
Diagnosis and management of uveal melanoma
44:11
44:11
Play later
Play later
Lists
Like
Liked
44:11
Despite recent advances in management of primary uveal melanoma, more than half of patients develop metastatic disease – often with poor outcomes. New therapeutic approaches to metastatic disease are vital. In this podcast, A/Prof Matteo Carlino interviews fellow Medical Oncologist Prof Georgina Long AO and Ophthalmologist A/Prof Max Conway on our …
…
continue reading
1
Getting the pathology right: Melanoma in General Practice
1:10:07
1:10:07
Play later
Play later
Lists
Like
Liked
1:10:07
Treating clinicians rely on pathology to help diagnose and stage their patient which fundamentally determines the treatment management plan. Therefore, it is incredibly important to get it right in the first place. In this engaging podcast aimed at GPs, our multidisciplinary experts discuss: Why can it be challenging to get the pathology right? Wha…
…
continue reading
1
Critical questions for a melanoma pathologist
36:26
36:26
Play later
Play later
Lists
Like
Liked
36:26
The role of pathology in the diagnosis and treatment of melanoma is pivotal to optimal patient care. With so many disciplines relying on the pathologist for accurate diagnoses and critical pathological information, we decided to reach out to our clinical melanoma community to ask them for their critical pathology questions. In this podcast, Prof Jo…
…
continue reading
Cancer drugs have rapidly evolved in the last decade. Alongside the significant benefits are new toxicity profiles that clinicians need to be aware of and manage. In this podcast, A/Prof Carlino interviews fellow Medical Oncologist Prof Georgina Long AO on the adverse events/toxicities associated with targeted therapies (combination BRAF/MEK inhibi…
…
continue reading
The field of melanoma has experienced a paradigm shift in recent years, with advancements in both diagnosis and management driving improved patient outcomes. Through the power of research, day-to-day practice continues to be transformed. In this lively podcast, two of Australia's leading melanoma experts Prof Richard Scolyer AO and Prof Georgina Lo…
…
continue reading
1
Multidisciplinary management of in-transit melanoma
28:04
28:04
Play later
Play later
Lists
Like
Liked
28:04
Managing in-transit melanoma can be challenging, and it presents and progresses as a heterogeneous disease. Multidisciplinary care is recommended for this complex disease to determine the optimal outcome for the patient. In this engaging podcast, our multidisciplinary expert panel - featuring a Dermatologist, Surgeon and Medical Oncologist - discus…
…
continue reading
1
Multidisciplinary management of primary melanoma
55:58
55:58
Play later
Play later
Lists
Like
Liked
55:58
Melanoma has many mimics, making detection a challenge. However, early detection and appropriate management of melanoma is crucial to ensuring a patient has the best chance of survival.By Melanoma Institute Australia
…
continue reading
1
Multidisciplinary management of Merkel cell carcinoma
28:35
28:35
Play later
Play later
Lists
Like
Liked
28:35
Due to the highly aggressive nature of Merkel cell carcinoma, accurate and timely diagnosis is essential to ensure optimal management. Although our understanding of the biology of the disease has advanced significantly in recent years, a clinical conundrum still exists regarding the ideal therapeutic strategy for each patient. In this podcast, our …
…
continue reading
1
Multidisciplinary management of SCC and BCC
46:09
46:09
Play later
Play later
Lists
Like
Liked
46:09
Hear our expert multidisciplinary panel discuss the latest management options for the treatment of squamous cell carcinoma and basal cell carcinoma - the most common forms of non-melanoma skin cancers. They have a wide clinical and pathological presentation, and early detection and treatment is vital to reduce the morbidity and mortality associated…
…
continue reading
1
The complexities of adjuvant therapy in melanoma
33:03
33:03
Play later
Play later
Lists
Like
Liked
33:03
The success of immunotherapy and targeted therapy in the treatment of advanced melanoma has led to the same therapies being used in the adjuvant setting to reduce the risk of recurrence. In this podcast, A/Prof Matteo Carlino interviews fellow Medical Oncologist A/Prof Alexander Menzies on the evidence for adjuvant therapy to guide clinical decisio…
…
continue reading
1
Emerging therapies in advanced melanoma in 2020
55:13
55:13
Play later
Play later
Lists
Like
Liked
55:13
In the rapidly evolving treatment landscape for advanced melanoma, medical oncologists now have a suite of treatments to choose from for their patients. In this engaging podcast, A/Prof Menzies interviews fellow Medical Oncologist A/Prof Carlino on the rationale behind their clinical decision making when it comes to choosing the most appropriate th…
…
continue reading
Melanoma is one of the most common human malignancies, however we often don't often think of it as a disease that occurs in children. Although exceedingly rare, clinicians do need to be aware of paediatric melanoma and have a high level of suspicion for these lesions as they are often diagnosed late. In this podcast, a Surgeon, Dermatologist and Me…
…
continue reading
1
When should I refer to a melanoma clinic?
34:10
34:10
Play later
Play later
Lists
Like
Liked
34:10
In the evolving treatment landscape of melanoma, it is important for GPs and Dermatologists to be confident in managing or knowing when to refer their melanoma patients. In this podcast, Surgeon A/Prof Robyn Saw, Dermatologist Dr Annika Smith and Skin Cancer GP Dr Adrian Quek discuss the ideal biopsy for a melanoma diagnosis, provides an overview o…
…
continue reading
1
What GPs need to know about melanoma patients on systemic therapies
26:06
26:06
Play later
Play later
Lists
Like
Liked
26:06
In the last decade, the treatment landscape for melanoma has been transformative for patients with advanced disease. Although managed primarily by medical oncologists, it is important for GPs to be across which treatments are available for their patients as they are often the first point of contact when a patient becomes unwell. In this podcast, Me…
…
continue reading
Thanks to advancements in therapy, we are now seeing large numbers of patients surviving advanced melanoma, and with that comes well-being and psychological challenges that need to be addressed. Clinicians need to be cognisant of their patients' needs beyond the medical side. Dietitian Jane Freeman, Psychologist Michelle Davey and Physiotherapist C…
…
continue reading
1
Management of Brain Metastases in Melanoma
38:46
38:46
Play later
Play later
Lists
Like
Liked
38:46
The management of melanoma patients with brain metastases has changed rapidly in the last five years, and patients now have much-improved survival rates. Brain metastases are no longer a death sentence and many people can have control of their disease with quality life. In this podcast, Medical Oncologist A/Prof Alex Menzies, Neurosurgeon Dr Brindh…
…
continue reading
